Financial Ratios

PRISM MEDICO AND PHARMACY LTD.

NSE : NABSE : 512217ISIN CODE : INE730E01016Industry : Finance - InvestmentHouse : Private
BSE13.720 (0 %)
PREV CLOSE ( ) 13.72
OPEN PRICE ( ) 13.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 22862
TODAY'S LOW / HIGH ( )13.50 13.72
52 WK LOW / HIGH ( ) 11.6237.2
NSE
This Company is not listed in NSE
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.04-0.13-0.61-0.21-0.08
   CEPS(Rs)-0.03-0.11-0.60-0.19-0.05
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)24.9725.0120.7121.3221.53
   Tax Rate(%)23.5725.3425.8625.8026.22
Margin Ratios
   Core EBITDA Margin(%)-4.71-7.63-5.80-0.97-0.19
   EBIT Margin(%)-0.71-8.02-5.90-1.04-0.25
   Pre Tax Margin(%)-0.96-8.04-5.91-1.05-0.25
   PAT Margin (%)-0.73-6.00-4.38-0.78-0.19
   Cash Profit Margin (%)-0.55-5.49-4.28-0.70-0.12
Performance Ratios
   ROA(%)-0.14-0.55-2.18-0.60-0.26
   ROE(%)-0.14-0.55-2.90-1.00-0.38
   ROCE(%)-0.14-0.74-3.91-1.35-0.52
   Asset Turnover(x)0.190.090.500.781.40
   Sales/Fixed Asset(x)80.8130.1763.6476.22122.27
   Working Capital/Sales(x)0.200.090.691.542.44
Efficiency Ratios
   Fixed Capital/Sales(x)0.010.030.020.010.01
   Receivable days527.231384.74397.56346.74149.95
   Inventory Days844.821944.81251.0953.286.85
   Payable days2.200.00178.61184.9582.41
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-1027.39-249.06-12.79-60.06-231.30
   Price/Book(x)1.091.140.370.550.58
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)5.6313.590.540.420.28
   EV/Core EBITDA(x)-1054.96-181.15-9.32-42.94-148.01
   EV/EBIT(x)-787.43-169.42-9.16-39.89-109.58
   EV/CE(x)1.091.140.370.320.34
   M Cap / Sales5.6513.660.550.420.28
Growth Ratio
   Net Sales Growth(%)130.20-84.95-49.63-37.66-25.93
   Core EBITDA Growth(%)83.6380.54-201.30-223.51-115.70
   EBIT Growth(%)79.4979.56-184.90-157.80-123.13
   PAT Growth(%)71.9579.37-184.50-158.70-113.60
   EPS Growth(%)71.9579.37-184.52-158.68-113.60
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)147.6865.35708.222.262.29
   Quick Ratio(x)80.9736.13319.611.702.29
   Interest Cover(x)-2.94-339.67-1083.14-709.78-272.12
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.